Skip to content

Effect of warm and cold uterine covering technique on intraoperative blood loss and uterotonic agent need, RCT in BAH.

Effect of warm and cold uterine covering technique on intraoperative blood loss and uterotonic agent need, RCT in BAH.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260605001
Enrollment
216
Registered
2026-06-05
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women with indications for a cesarean section Pregnant women with indications for a cesarean section

Interventions

Cold Uterine Covering Group Following the delivery of the infant and placenta, the uterus is covered with a sterile surgical lap sponge soaked in cold normal saline. This covering is maintained throug
Experimental Procedure/Surgery,Experimental Procedure/Surgery
Cold uterine covering ,Warm uterine covering

Sponsors

Bhumibol Adulyadej Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 34 Years

Inclusion criteria

Inclusion criteria: 1.Pregnant women aged more than 20 years 2.Pregnant women with a singleton pregnancy and a 3.gestational age of more than 32 weeks 4.Pregnant women with indications for a cesarean section

Exclusion criteria

Exclusion criteria: 1.Pregnant women suspected of or diagnosed with placenta previa or placenta accreta either antenatally or intraoperatively 2.Pregnant women with a history of a non-lower segment uterine incision .3.Pregnant women with sepsis or chorioamnionitis (amniotic fluid infection) 4.Pregnant women with severe preeclampsia 5.Pregnant women with a history of postpartum hemorrhage (PPH) 6.Pregnant women with a history of hypersensitivity or allergy to misoprostol, oxytocin, or ergometrine/methylergometrine 7.Pregnant women with a history of thromboembolic diseases that contraindicate the use of Tranexamic Acid (Transamine), such as deep vein thrombosis (DVT), pulmonary embolism, stroke, or myocardial infarction

Design outcomes

Primary

MeasureTime frame
Blood loss Cesarean section Ml

Secondary

MeasureTime frame
Hemoglobin During Cesarean section Mg/L

Countries

Thailand

Contacts

Public ContactSiriprapa Tienchaisiri

Bhumibol Adulkyadej hospital

fern2485@hotmail.com0951618487

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026